Antibody Discovery News and Research

RSS
Research uncovers antibodies that are still effective against new variants of SARS-CoV-2

Research uncovers antibodies that are still effective against new variants of SARS-CoV-2

Antiverse raises funding and demonstrates therapeutic antibody identification with AI-driven drug discovery platform

Antiverse raises funding and demonstrates therapeutic antibody identification with AI-driven drug discovery platform

Researchers develop AI-based strategy for discovering high-affinity antibody drugs

Researchers develop AI-based strategy for discovering high-affinity antibody drugs

Berkeley Lights launches Beacon Select™, a new optofluidic system for cell line development

Berkeley Lights launches Beacon Select™, a new optofluidic system for cell line development

High affinity antibodies isolated to safely target Claudin 6-positive tumors

High affinity antibodies isolated to safely target Claudin 6-positive tumors

Antibody discovery could explain why so many group A strep vaccines have failed

Antibody discovery could explain why so many group A strep vaccines have failed

Broadly cross-reactive antibodies that protect from SARS-CoV-2 variants are revealed by virus coldspot-driven discovery

Broadly cross-reactive antibodies that protect from SARS-CoV-2 variants are revealed by virus coldspot-driven discovery

Hemagglutinin stem immunogens may hold the key for broad protection against influenza A viruses

Hemagglutinin stem immunogens may hold the key for broad protection against influenza A viruses

Study provides a guide to neutralizing Lassa virus using a trio of rare antibodies

Study provides a guide to neutralizing Lassa virus using a trio of rare antibodies

Insights into the products and services of Azenta

Insights into the products and services of Azenta

LJI acquires Carterra LSA instrument to enhance antibody screening and characterization efforts

LJI acquires Carterra LSA instrument to enhance antibody screening and characterization efforts

Curia Adopts the Berkeley Lights Platform to Expand its Antibody Discovery Capabilities

Curia Adopts the Berkeley Lights Platform to Expand its Antibody Discovery Capabilities

Antibodies that neutralize most sarbecoviruses, including SARS-CoV-2 variants

Antibodies that neutralize most sarbecoviruses, including SARS-CoV-2 variants

Fortis Life Sciences acquires Abcore, a leader in nanobody technologies

Fortis Life Sciences acquires Abcore, a leader in nanobody technologies

New cryo-EM method may be able to shortcut a big step in modern vaccine development

New cryo-EM method may be able to shortcut a big step in modern vaccine development

Novel antibody that targets the N-terminal domain of SARS-CoV-2 identified

Novel antibody that targets the N-terminal domain of SARS-CoV-2 identified

Production of molecular probes of spike and subdomains for all SARS-CoV-2 variants

Production of molecular probes of spike and subdomains for all SARS-CoV-2 variants

The use of monoclonal antibodies against infectious pathogens

The use of monoclonal antibodies against infectious pathogens

Sartorius strengthens its bioanalytics portfolio by acquiring a majority stake in ALS Automated Lab Solutions

Sartorius strengthens its bioanalytics portfolio by acquiring a majority stake in ALS Automated Lab Solutions

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.